Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Blood|April 5, 2023
Mechanosensing via a GpIIb/Src/14-3-3ζ axis critically regulates platelet migration in vascular inflammationRainer Kaiser, Afra Anjum, Lisa Kammerer, et al.
Oncotarget|December 30, 2017
Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306)Dominik Paul Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2025
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306Julian Walter Holch, Alexander J Ohnmacht, Sebastian Stintzing, et al.
International Journal of Cancer|November 22, 2021
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3)Markus Moehler, Gunnar Folprecht, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2025
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancerLena Weiss, Sebastian Stintzing, Arndt Stahler, et al.
International Journal of Cancer|July 26, 2021
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3)Arndt Stahler, Volker Heinemann, Julian Walter Holch, et al.
International Journal of Cancer|October 20, 2017
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trialJulian Walter Holch, Ingrid Ricard, Sebastian Stintzing, et al.
Medical Image Analysis|December 8, 2022
The Liver Tumor Segmentation Benchmark (LiTS)Patrick Bilic, Patrick Christ, Hongwei Bran Li, et al.
Pageof 2